Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution
The FDA Law Blog
MAY 26, 2025
Second, absent some kind of contractual relationship between a provider and a manufacturer, a provider is generally immune from misbranding if the provider is not also selling a regulated product.
Let's personalize your content